
				
					Zhao Tao is the chairman of Shandong Buchang Pharmaceuticals, a supplier of traditional Chinese medicine to fight cardiovascular disease. 
				
				
					Zhao holds an MBA from Fordham University in New York City. 
				
				
					Buchang started trading on the Shanghai Stock Exchange on November 18, 2016.
				
		